← FDA DRUG APPROVALS

FDA ANDA · ANDA062557

KEFZOL

Sponsor: LILLY

APPLICATION
ANDA062557
TYPE
ANDA
ORIGINAL APPROVAL
1985-09-10
LATEST ACTION
2002-09-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

KEFZOLDiscontinued
CEFAZOLIN SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
KEFZOLDiscontinued
CEFAZOLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2002-09-30Manufacturing (CMC) · Supplement 14AP
2002-09-05Manufacturing (CMC) · Supplement 13AP
1992-10-30Manufacturing (CMC) · Supplement 8AP
1992-01-22Labeling · Supplement 6AP
1991-07-16Manufacturing (CMC) · Supplement 7AP
1985-09-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →